BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27329045)

  • 21. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
    Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
    Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
    Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis.
    Hattar K; Sibelius U; Bickenbach A; Csernok E; Seeger W; Grimminger F
    J Leukoc Biol; 2001 Jan; 69(1):89-97. PubMed ID: 11200073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis.
    Matsumoto T; Kaneko T; Seto M; Wada H; Kobayashi T; Nakatani K; Tonomura H; Tono Y; Ohyabu M; Nobori T; Shiku H; Sudo A; Uchida A; Kurosawa DJ; Kurosawa S
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):186-92. PubMed ID: 18372277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using a Caesalpinia echinata Lam. protease inhibitor as a tool for studying the roles of neutrophil elastase, cathepsin G and proteinase 3 in pulmonary edema.
    Cruz-Silva I; Neuhof C; Gozzo AJ; Nunes VA; Hirata IY; Sampaio MU; Figueiredo-Ribeiro Rde C; Neuhof H; Araújo Mda S
    Phytochemistry; 2013 Dec; 96():235-43. PubMed ID: 24140156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism.
    Hinkofer LC; Seidel SA; Korkmaz B; Silva F; Hummel AM; Braun D; Jenne DE; Specks U
    J Biol Chem; 2013 Sep; 288(37):26635-48. PubMed ID: 23902773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils.
    Pederzoli M; Kantari C; Gausson V; Moriceau S; Witko-Sarsat V
    J Immunol; 2005 May; 174(10):6381-90. PubMed ID: 15879139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinase 3 expression on neutrophil membranes from patients with infectious disease.
    Matsumoto T; Kaneko T; Wada H; Kobayashi T; Abe Y; Nobori T; Shiku H; Stearns-Kurosawa DJ; Kurosawa S
    Shock; 2006 Aug; 26(2):128-33. PubMed ID: 16878019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3.
    Coeshott C; Ohnemus C; Pilyavskaya A; Ross S; Wieczorek M; Kroona H; Leimer AH; Cheronis J
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6261-6. PubMed ID: 10339575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
    Hu N; Westra J; Kallenberg CG
    Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
    Gross WL; Csernok E; Flesch BK
    J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener's autoantigen, in RBL cells: implication for its pathogenic activity.
    Kantari C; Millet A; Gabillet J; Hajjar E; Broemstrup T; Pluta P; Reuter N; Witko-Sarsat V
    J Leukoc Biol; 2011 Nov; 90(5):941-50. PubMed ID: 21821719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.
    Kessenbrock K; Fröhlich L; Sixt M; Lämmermann T; Pfister H; Bateman A; Belaaouaj A; Ring J; Ollert M; Fässler R; Jenne DE
    J Clin Invest; 2008 Jul; 118(7):2438-47. PubMed ID: 18568075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
    Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
    Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3.
    Hwang TL; Wang WH; Wang TY; Yu HP; Hsieh PW
    Bioorg Med Chem; 2015 Mar; 23(5):1123-34. PubMed ID: 25650311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibitors of human neutrophil proteinase 3.
    Korkmaz B; Kellenberger C; Viaud-Massuard MC; Gauthier F
    Curr Pharm Des; 2013; 19(6):966-76. PubMed ID: 23016687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.